Advertisement

Internal Medicine

Home Internal Medicine

Telmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients

African American-specific beneficial effects of telmisartan identified in Mendelian randomization analysis

The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices

Excessive FDA Regulation Driving High Drug Prices

First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved
More than a quarter-million Vietnam veterans suffer from posttraumatic stress disorder symptoms today

PTSD Symptoms Persist for Thousands of Vietnam Vets

It's never too late to seek help, experts say
Diets higher in plant-based foods and lower in animal-based foods are associated with lower risks for developing or dying from cardiovascular disease among middle-aged adults

Plant-Based Diets May Lower CV Disease, Deaths in Middle-Aged

Association also found for reduction in all-cause mortality but not incident cardiovascular disease
The ongoing Ebola outbreak in the Democratic Republic of Congo has claimed the lives of nearly 100 children

Congo Ebola Outbreak Claims Nearly 100 Children’s Lives

Number of new cases surged in January, from about 20 a week to more than 40
From 1996 to 2010 there was a significant increase in intermediate care billing

Intermediate Care Billing Rose From 1996 to 2010

Fewer organ failures, less mechanical ventilation, lower 30-day death for intermediate vs ICU billing
Improving adherence to healthy dietary patterns may help reduce the genetic association with weight gain

Adherence to Healthy Diet May Cut Effects of Genetics on Obesity

Long-term, improved diet quality benefits weight control in those with high genetic risk of obesity
Expanding Medicaid to all states could reduce the number of uninsured by 28 percent based on pre-COVID-19 data

Expanding Medicaid in Holdout States Could Insure 3.9 Million

Given the increase in uninsured due to COVID-19-related unemployment, this estimate is likely low
Evolocumab and inclisiran

ACC: Meds Targeting PCSK9 Show Benefit for High-Risk Patients

Evolocumab and inclisiran inhibit proprotein convertase subtilisin-kexin type 9
For patients receiving single chamber implantable cardioverter defibrillators

Long Detection Programming Cuts Unnecessary Therapies

Findings among patients receiving single chamber implantable cardioverter defibrillators